Hotimah Masdan Salim

Hotimah Masdan Salim

Universitas Nahdlatul Ulama Surabaya - Surabaya / Indonesia
Medical and Health Sciences / Pharmacology
AD Scientific Index ID: 4486649
Nahdlatul Ulama University Surabaya
person_outline Hotimah Masdan Salim's MOST POPULAR ARTICLES
1-) Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitusS Yagi, Y Hirata, T Ise, K Kusunose, H Yamada, D Fukuda, HM Salim, ...Diabetology & metabolic syndrome 9 (1), 1-7, 20171062017
2-) Glycemic control with ipragliflozin, a novel selective SGLT2 inhibitor, ameliorated endothelial dysfunction in streptozotocin-induced diabetic mouseHM Salim, D Fukuda, S Yagi, T Soeki, M Shimabukuro, M SataFrontiers in cardiovascular medicine 3, 43, 2016972016
3-) Canagliflozin prevents diabetes-induced vascular dysfunction in ApoE-deficient miceA Rahadian, D Fukuda, HM Salim, S Yagi, K Kusunose, H Yamada, ...Journal of Atherosclerosis and Thrombosis 27 (11), 1141-1151, 2020492020
4-) Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic …HM Salim, D Fukuda, Y Higashikuni, K Tanaka, Y Hirata, S Yagi, T Soeki, ...Vascular Pharmacology 96, 19-25, 2017502017
5-) Dipeptidyl peptidase-4 inhibitor, linagliptin, ameliorates endothelial dysfunction and atherogenesis in normoglycemic apolipoprotein-E deficient miceHM Salim, D Fukuda, Y Higashikuni, K Tanaka, Y Hirata, S Yagi, T Soeki, ...Vascular Pharmacology 79, 16-23, 2016492016